Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

OssDsign® Spine Registry Study ("Propel")

NCT: NCT05329129 · RECRUITING

NCT IDNCT05329129
StatusRECRUITING
Start Date2022-03-23
Completion2030-04-01
SponsorOssDsign (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑